Alzheimer’s disease affects more than 7 million Americans. While new drugs have offered some relief, they haven’t done enough and some have serious side effects. WashU researchers are working on a new approach that they hope will help the body recognize and clear away the harmful proteins that drive Alzheimer’s — without the dangerous side effects.